163 related articles for article (PubMed ID: 27062606)
1. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.
Couque N; Girard D; Ducrocq R; Boizeau P; Haouari Z; Missud F; Holvoet L; Ithier G; Belloy M; Odièvre MH; Benemou M; Benhaim P; Retali B; Bensaid P; Monier B; Brousse V; Amira R; Orzechowski C; Lesprit E; Mangyanda L; Garrec N; Elion J; Alberti C; Baruchel A; Benkerrou M
Br J Haematol; 2016 Jun; 173(6):927-37. PubMed ID: 27062606
[TBL] [Abstract][Full Text] [Related]
2. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).
Wang WC; Ware RE; Miller ST; Iyer RV; Casella JF; Minniti CP; Rana S; Thornburg CD; Rogers ZR; Kalpatthi RV; Barredo JC; Brown RC; Sarnaik SA; Howard TH; Wynn LW; Kutlar A; Armstrong FD; Files BA; Goldsmith JC; Waclawiw MA; Huang X; Thompson BW;
Lancet; 2011 May; 377(9778):1663-72. PubMed ID: 21571150
[TBL] [Abstract][Full Text] [Related]
3. Madrid Newborn Sickle Cell Disease Cohort: clinical outcomes, stroke prevention and survival.
García-Morin M; Bardón-Cancho EJ; Beléndez C; Dulín E; Blanco-Soto P; Puertas-López C; Prieto-Medina M; Cervera-Bravo Á; Llorente-Otones L; Pérez-Alonso V; San-Román S; Vecilla-Rivelles C; López-Rubio M; Sebastián E; Bellón JM; Cela E
Ann Hematol; 2024 Feb; 103(2):373-383. PubMed ID: 37980280
[TBL] [Abstract][Full Text] [Related]
4. Children with HbSβ
Day ME; Rodeghier M; DeBaun MR
Pediatr Blood Cancer; 2018 Nov; 65(11):e27352. PubMed ID: 30094930
[TBL] [Abstract][Full Text] [Related]
5. Adherence to transcranial Doppler screening guidelines among children with sickle cell disease.
Eckrich MJ; Wang WC; Yang E; Arbogast PG; Morrow A; Dudley JA; Ray WA; Cooper WO
Pediatr Blood Cancer; 2013 Feb; 60(2):270-4. PubMed ID: 22744996
[TBL] [Abstract][Full Text] [Related]
6. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.
Colombatti R; Palazzi G; Masera N; Notarangelo LD; Bonetti E; Samperi P; Barone A; Perrotta S; Facchini E; Miano M; Del Vecchio GC; Guerzoni ME; Corti P; Menzato F; Cesaro S; Casale M; Rigano P; Forni GL; Russo G; Sainati L;
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28868627
[TBL] [Abstract][Full Text] [Related]
7. Survival of children with sickle cell disease.
Quinn CT; Rogers ZR; Buchanan GR
Blood; 2004 Jun; 103(11):4023-7. PubMed ID: 14764527
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns of stroke screening and hydroxyurea use in children with sickle cell disease: a survey of health care providers.
Madden NA; Jones GL; Kalpatthi R; Woods G
J Pediatr Hematol Oncol; 2014 Aug; 36(6):e382-6. PubMed ID: 24714503
[TBL] [Abstract][Full Text] [Related]
9. The effect of hydroxcarbamide therapy on survival of children with sickle cell disease.
Lobo CL; Pinto JF; Nascimento EM; Moura PG; Cardoso GP; Hankins JS
Br J Haematol; 2013 Jun; 161(6):852-60. PubMed ID: 23590693
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.
Stallworth JR; Jerrell JM; Tripathi A
Am J Hematol; 2010 Oct; 85(10):795-7. PubMed ID: 20645429
[TBL] [Abstract][Full Text] [Related]
11. [The use of hydroxyurea in severe forms of sickle cell disease: study of 47 Tunisian paediatric cases].
Mellouli F; Bejaoui M
Arch Pediatr; 2008 Jan; 15(1):24-8. PubMed ID: 18164913
[TBL] [Abstract][Full Text] [Related]
12. The risk of acute events among patients with sickle cell disease in relation to early or late initiation of care at a specialist center: evidence from a retrospective cohort study.
Rankine-Mullings AE; Logan TM; King LG; Cunningham-Myrie CA; Scott CR; Knight-Madden JM
BMC Pediatr; 2020 Aug; 20(1):373. PubMed ID: 32770992
[TBL] [Abstract][Full Text] [Related]
13. Improving care for children with sickle cell disease/acute chest syndrome.
Crabtree EA; Mariscalco MM; Hesselgrave J; Iniguez SF; Hilliard TJ; Katkin JP; McCarthy K; Velasquez MP; Airewele G; Hockenberry MJ
Pediatrics; 2011 Feb; 127(2):e480-8. PubMed ID: 21242225
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia.
Quinn CT; Shull EP; Ahmad N; Lee NJ; Rogers ZR; Buchanan GR
Blood; 2007 Jan; 109(1):40-5. PubMed ID: 16940426
[TBL] [Abstract][Full Text] [Related]
15. Secondary benefit of maintaining normal transcranial Doppler velocities when using hydroxyurea for prevention of severe sickle cell anemia.
Ghafuri DL; Chaturvedi S; Rodeghier M; Stimpson SJ; McClain B; Byrd J; DeBaun MR
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035747
[TBL] [Abstract][Full Text] [Related]
16. Score Predicting Acute Chest Syndrome During Vaso-occlusive Crises in Adult Sickle-cell Disease Patients.
Bartolucci P; Habibi A; Khellaf M; Roudot-Thoraval F; Melica G; Lascaux AS; Moutereau S; Loric S; Wagner-Ballon O; Berkenou J; Santin A; Michel M; Renaud B; Lévy Y; Galactéros F; Godeau B
EBioMedicine; 2016 Aug; 10():305-11. PubMed ID: 27412264
[TBL] [Abstract][Full Text] [Related]
17. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
18. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
[TBL] [Abstract][Full Text] [Related]
19. Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.
Akar NA; Adekile A
Med Princ Pract; 2008; 17(5):404-8. PubMed ID: 18685282
[TBL] [Abstract][Full Text] [Related]
20. [Screening of cerebral vasculopathy in sickle cell anemia children using transcranial Doppler].
Dorie A; Guindo A; Saro YS; Touré BA; Fané B; Dembelé AK; Diallo DA
Arch Pediatr; 2015 Mar; 22(3):260-6. PubMed ID: 25636211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
